Cargando…
Prescription Opioid Use in Patients With and Without Systemic Lupus Erythematosus — Michigan Lupus Epidemiology and Surveillance Program, 2014–2015
Autores principales: | Somers, Emily C., Lee, Jiha, Hassett, Afton L., Zick, Suzanna M., Harlow, Siobán D., Helmick, Charles G., Barbour, Kamil E., Gordon, Caroline, Brummett, Chad M., Minhas, Deeba, Padda, Amrita, Wang, Lu, McCune, W. Joseph, Marder, Wendy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762189/ https://www.ncbi.nlm.nih.gov/pubmed/31557148 http://dx.doi.org/10.15585/mmwr.mm6838a2 |
Ejemplares similares
-
Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
por: Charoenwoodhipong, Prae, et al.
Publicado: (2020) -
'MiLES' population-based survey of the incidence and prevalence of systemic lupus erythematosus in Southeastern Michigan
por: Somers, EC, et al.
Publicado: (2012) -
Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries
por: Izmirly, Peter M, et al.
Publicado: (2021) -
Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies
por: Marder, Wendy, et al.
Publicado: (2014) -
Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients
por: Somers, Emily C., et al.
Publicado: (2012)